oneKNEE - Prospective, Non-interventional, Multicenter PMCF-Study

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-79
SponsorAesculap AG

About this trial

Safety and Clinical Performance in terms of clinical outcome of oneKNEE® (total knee arthroplasty TKA), evaluated 2 years after implantation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient age ≤ 80 years

Indication for a total knee replacement with one of the variants

Written informed consent

Willingness and mental ability to participate at the long-term follow-up examinations

Disqualifiers

Contraindications acc. to the Instructions for Use (IFU)

Patient age < 18 years

Known pregnancy

BMI > 40

Trial population

Patients receiving a total knee prosthesis

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • oneKNEE®

    Device

    Total knee prostheses

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Safety of the implant

Safety in terms of clinical outcome of oneKNEE® All adverse device effects: serious and non-serious adverse events with relation to either the product or the surgical procedure.

Time frame
2 years after implantation
2

Clinical Performance in terms of clinical outcome of oneKNEE®

Clinical Performance in terms of clinical outcome of oneKNEE®. Difference in Oxford Knee Score (OKS) 2 years after implantation compared to preoperative state. The Oxford Knee Score (OKS) is a validated joint-specific patient-reported outcome measure that is commonly employed to assess the outcome of TKA. It is a 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing TKA. It is short, reproducible, valid and sensitive to clinically important changes over time. OKS ranges from 0 to 48 with 48 being the best outcome.

Time frame
2 years after implantation

Secondary outcomes

1

Clinical Outcome by evaluating the Oxford Knee Score

The Oxford Knee Score, OKS is a validated joint-specific patient-reported outcome measure that is commonly employed to assess the outcome of TKA. It is a 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing TKA. It is short, reproducible, valid and sensitive to clinically important changes over time. OKS ranges from 0 to 48 with 48 being the best outcome.

Time frame
V4=3 months post OP, V5= 1year p.OP, V6= 2years p.OP, V7= 5years p.OP
2

Evaluation of Changes in Quality of Life

The EQ-5D-5L is a standardized instrument used to measure health outcomes. Developed by the EuroQol Group (EQ), it assesses five dimensions (5D) of health: Mobility Self-care Usual activities Pain/discomfort Anxiety/depression Each dimension has five levels (5L) of severity: no problems, slight problems, moderate problems, severe problems, and extreme problems

Time frame
V1= pre OP, V3= Discharge, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,
3

Evaluation of Patient Satisfaction by using PROMS: FJS

Forgotten Joint Score (FJS) : A joint-specific questionnaire with the aim to measure PRO of joint disorders . FJS is designed to measure the ability of the patient to "forget" about their problematic joint after treatment. Scale: * 12 questions (How often are you aware of your affected knee joint in everyday life?) * 5-point response scale (0-4) * responses are then summed and divided by the number of completed items * mean value is then multiplied by 25 to obtain the total score of 0-100. A higher score indicates that the patient is less aware of their joint, suggesting better surgical outcomes and higher levels of patient satisfaction.

Time frame
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
4

Anterior knee pain

Anterior knee pain is used to evaluate the performance of the implantation and the implant itself. Rating is classified according to the description of Waters and Bentley in four dimensions: 0 (no pain), I (Mild pain that does not intrude on daily activities), II (Moderate pain that is a nuisance; patient not considering further surgery), III (Severe pain; Patient considering further surgery). The scoring is according to Feller et al. 0, 5, 10 and 15 points, respectively. (Feller et al., J Bone Joint Surg Am. 2003 Feb;85(2):212-7).

Time frame
V1= preoperatively, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: